recent study (8) . H owever, all other reports have not been able to con rm the association of p53 codon 72 arginine at codon 72 of the p53 tumour suppressor gene and susceptibility to develop human papilloma virus (HPV )-associated cervical homozygotes with increased risk for cervical cancer (9-23 ). Intriguingly, 2 separate investigations (8, 23) based on the cancer have been published over the last year, implicating diOE erences in ethnic background, sample origin, sample size analysis of cervical SCCs from the identical geographical region have produced con icting results. Our study include and / or detection assay. The material for this study was collected in the identical geographical region as for 2 previous reports both SCC and adenocarcinoma cases collected from Swedish women in the same region as in the 2 reports with con icting with contradictory results regarding the association of codon 72 genotype with squamous cell cancer (SCC). We have used an data mentioned above. In total we screened the codon 72 genotypes of 141 clinical samples, including adenocarcinoma, alternative detection assay, based on pyrosequencing technology, that interrogates the variable position by the accuracy of DNA SCC, cervical intraepithelial neoplasia (CIN ) and nonneoplastic specimens. An alternative D N A sequencing assay, polymerase. In addition to cervical clinical specimens from SCC, HPV16-and HPV18-infected adenocarcinoma cases as well as pyrosequencing (24), that accurately determines the SN P and its adjacent positions was used. Sweden. E-mail: joakim.lundeberg@biochem.kth.se preferentially selected high-risk H PV-infected cases from the cervica l non-neoplastic control, CIN and cancer patient material available. H owever , H PV-negative or H PV low-risk infected control cases were included to increase the case number . Tissues from formalin xed, Adenocarcinoma and squamous cell carcinoma (SCC ) of the para n-embedded specimens of 39 cervica l adenocarcino ma, 20 SCC, cervix are both associated with high-risk human papilloma 46 CIN (CIN1, 2 and 3) and 36 non-neoplastic cases were included in this study.
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virus (H PV ) infection (1, 2). The E6 oncoprotein from highrisk H PV binds to and induces ubiquitin-mediated degradation of the p53 protein (3, 4) and thereby contributes to the DNA preparation development of cervical cancer. Thus, this E6-mediated inacOne to three 10 l m section s were made from each case accordin g to tivation of p53 can be functionally equivalent to inactivating size of tissues available for testing. All tumour samples contained a p53 mutations. M utant p53 variants have been shown to be mixture of tumour cells and normal tissue (stroma, adjacent normal resistant to E6-mediated degradation (5) and speci c E6 epithelia and in ltrating in ammatory cells). M icrodissection was not variants have been proposed to be more prevalent in invasive performed. Tissue section s were depar a nized by routine procedure. D NA samples were prepared from tissue section s by digestin g with cervical tumours than the prototype (6). These ndings indiproteinase K treatment, 1.0 l g/l l (Boehringer M annheim, G mbH, cate that the interaction between p53 and E6 can be modulated G ermany) at 56°C overnight . After incubatio n at 95°C for 10 min, and may have implications for the development of cervical samples were stored at ± 20°C for subsequen t analysis.
carcinoma.
The single nucleotide polymorphism (SN P ) in p53 exon 4
H PV detection and typing codon 72, either CG C (arginine) or CCC (proline), was rst suggested to play a role in the development of H PV-associated were 7 times more susceptible to develop H PV-associated
In brief, low-or high-risk speci c R NA probes were hybridized to the biotinylated PCR product . Following solid-phase capture the cancer. The association to cervical SCC was con rmed in a D NA/R NA hybrids were allowed to bind to an antihybrid/alkaline M 280; D ynal, Oslo, N orway) in 30 l l BW buOE er (10 mM Tris-HCl (pH 7.6), 2.7 M N aCl, 1 mM ED TA, 0.1% Tween 20) for 30 min at phosphata se antibody, which was detected by addition of the colori-43°C. Single stranded D NA was obtained by incubatin g the immobilmetric substrate para-nitrophenylphenol . The detection and typing of ized PCR product in 20 l l 0.1 M N aOH for 5 min. The immobilized H PV types 16 and 18 was performed by PCR with genera l primers strand was resuspended in annealing buOE er (10 mM Tris-OOCH 3 and single-stranded conformation polymorphism (SSCP) (26). pH 7.75, 2 mM M gOOCH 3 ) containin g 1 pmol sequencin g primer (5¢ -GCTG CTGGTG CAGG GGCCA-3¢ ) in a total volum e of 10 l l. All steps were automated and performed in 96-well format using PCR and template preparation in-house robotics (A. H olmberg, unpublished ). Primer hybridization was performed by incubatio n at 94°C for 20 s, 65°C for 2 min and The p53 exo n 4 was ampli ed by nested PCR as outlined in R ef. 27. subsequen t coolin g to room temperature. Thirty l l of 10 mM TrisThe outer PCR (initial denatura tion 94°C for 5 min followed by 94°C OOCH 3 pH 7.6 buOE er was added to the single stranded D NA template 30s, 50°C 1 min and 72°C 1 min for 30 cycles, followed by a nal before sequencing. Thereafter, real-time pyrosequencin g at 28°C in a 10 min extension at 72°C ) was followed by a nested inner PCR (initial total volum e of 50 l l was performed on an automated 96-well PSQ denatura tion 94°C for 5 min followed by 94°C 1 min, 50°C 40s and 96 instrumen t using enzymes and substrates from the PSQ 96 SNP 72°C 1 min for 35 cycles, followed by a 10 min extension at 72°C ), reagen t kit (Pyrosequencin g AB, U ppsala , Sweden). generated a 79 bp PCR product for pyrosequencing . F ive l l (approximately 500-1000 cells/l l ) was used as template for the outer PCR . The outer ampli cation mixture comprised 10 mM Tris-HCl (pH 8.3), S tatistical analysis 2 mM M gCl 2 , 50 mM K Cl, 0.1% Tween 20, 0.2 mM dN TPs, The prevalence of diOE erent genotypes amon g adenocarcino ma, 5 pmol of each primer (5¢ -AGAGGAATCCCAAAGTTCCA-3¢ ; SCC, dysplastic and non-neoplastic cases were statistically assessed 5¢ -CTGG GACCTG GAG GGCTG G-3¢ ) and 1. 
proline (CCC ) or arginine (CG C
normal Swedish population have previously been determined genotypes. The sequencing primer was positioned penultimate to be 11-12% proline homozygotes, 50-53% arginine homoto the SN P. The rst introduced nucleotide, T, was deliberately zygotes and 35-39% proline/arginine heterozygotes (23, 28 ). chosen not to be complementary in order to yield a background Comparable frequencies were found in this study, although control signal. The subsequently added nucleotide, C, was proline homozygotes were slightly less represented (3-7%) and incorporated and identical for all allelic variants and set to heterozygotes were slightly more represented (47-48%). An correspond to 1 peak equivalent (extension on both alleles).
overestimation of homozygotes due to loss of heterozygosity The third nucleotide addition, G , interrogates the variable (LOH ) is also not likely since most previous investigations position by yielding 6, 3.5 or 1 peak equivalent base incorporahave reported none or low frequencies of LOH involving 17p tion for the homozygou s C (proline), heterozygous C/G in cervical cancer (0-22%) (7, (29) (30) (31) . In addition, LOH in (proline/arginine) and homozygou s G (arginine), respectively. our samples would probably be masked by signals from the Another addition of G nucleotides was made to ensure comsigni cant amounts of normal cells. plete incorporation. Thereafter, nucleotides C and G were This study show that the codon 72 genotype distribution added sequentially to extend the lagging arginine allele. The among high-risk H PV-infected patients with cervical adenocarpredicted patterns for the polymorphism is shown below cinoma is similar to controls in the Swedish population, (F ig. 1) and the similarities between raw-data and the three indicating that no variant of the polymorphism at p53 codon predicted patterns allowed for direct and reliable scoring of 72 elevate the risk of developing adenocarcinoma of the cervix. the codon 72 polymorphism.
Additional v 2 tests and multivariate logit-regression analysis The distribution of the p53 codon 72 polymorphism among using the normal population (23, 28) as control con rmed the the investigated Swedish cases using the pyrosequencing detecresults (data not shown). These ndings are in concordance tion assay are summarized in Table I . All samples were conwith the single previous study of the association of this rmed by a repeated analysis starting from the lysed sample.
polymorphism with cervical adenocarcinoma based on an The frequency of codon 72 genotypes in the non-neoplastic eastern American population (22). Considering the possible population was determined to be: 2.8% proline homozygou s diOE erential impact of H PV type speci c E6 sequences, we cases, 50% arginine homozygou s and 47.2% proline/arginine investigated both H PV 16 and H PV 18-infected adenocarcinheterozygous cases with no diOE erence in distribution of genooma cases. In order to better compare non-neoplastic and types observed between the H PV positive and H PV negative neoplastic groups, we have also selected controls comprising controls ( p = 0.6852). The codon 72 genotype frequency an increased proportion of high-risk H PV-infected cases. among patients with adenocarcinoma was similar to non-H owever, no diOE erences were found in the distribution of neoplastic controls ( p = 0.2064) . N o distinction was observed codon 72 frequencies either between H PV 16 and 18-infected between H PV 16 and H PV 18 positive adenocarcinoma cases adenocarcinomas or H PV-negative and H PV-positive controls. ( p = 0.2663) . M oreover, we did not nd any signi cant overOur data suggest that the p53 codon 72 polymorphism is representation of homozygotes for the arginine allele among not associated with increased probability of high-risk H PVeither the SCC ( p = 0.6486 ) or CIN patients ( p = 0.7154 ) as infected Swedish patients to develop CIN or cervical SCC. compared to non-neoplastic controls.
M ultivariate logit-regression analysis and v 2 tests using the normal population (23, 28) as control also con rmed these results (data not shown). This report represents the third study investigating the association between SCC of the cervix and or heterozygous C/G ) will give a unique sequence pattern, which makes typing extremely robust. Simple manual compar- (duplicates) was also con rmed by R F LP analysis (A.C.
1631.
G ustafsson, unpublished ).
11. R osentha l AN, R yan A, Al-Jehani R M , from an indirect screening procedure, such as SSCP (8), is polymorphism at codo n 72 of p53 and risk of cervica l cancer in con rmed with an alternative strategy (D N A sequencing).
